Imbruvik
(Ibrutinib)
(140 mg)
(thirty)
(Tablets)
Ibrutinib 140 mg 30 tab Hetero India
Article:
In Stock
Generic analogue of Ibruvik, Imbruvik
Indications
- Ibrutinib is indicated for the treatment of mantle-clitinous lymphoma in adult patients who have relapsed or have not responded to previous treatment.
- Ibrutinib is indicated for the treatment of chronic lymphocytic leukemia in adult patients who have received at least one course of treatment, or as first-line therapy for the presence of a 17p deletion or TP53 mutation in patients who are not eligible for chemoimmunotherapy.
- 1400pash
-
Commercial name:Imbruvik
-
Сhemical name:Ibrutinib
-
Dosage:140 mg
-
Quantity:thirty
-
Release form:Tablets
-
Виробник:Hetero, индия
No reviews yet